泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

Thirty patients with confirmed primary sjogren syndrome and thrombocytopenia during January 2002 and December 2007 were investigated.All the participants received 0.5 mg·kg-1·d-1 Prednisone and 100 ms/d CosA for 1 year.Clinical symptoms and the levels of white blood eell.platelet count,erythrocyte sedimentation rate,liver function,immunoglobin,and rheumatoid factors were recored before and after the treatment.After one-year follow.up,platelet count was elevated(t=11.4179,P< 0.01).There was no significant change in erythrocyte sedimentation rate.The concentrations of immunoglobin and rheumatoid factors were significantly decreased at 1 year(t=5.4222,P<0.01;t= 9.2857.P<0.01).Prednisone plus CosA could effectively treat primary sjOgren syndrome combined with thrombocytopenia and result in fewer side effects.     

白芍总苷治疗强直性脊柱炎

目的研究白芍总苷治疗强直性脊柱炎（AS）的疗效，并与柳氮磺砒啶（SSZ）进行对照。方法55例活动性As分别用白芍总苷（0．6g，每天3次）及柳氮磺砒啶（1．0g，每天2次）治疗，疗程24周，对两药在第6、12、24周疗效及观察指标进行评估。结果白芍总苷在第6、12、24周的有效率分别为63．3％、80．0％、86．7％，柳氮磺砒啶为44．0％、68．0％、64．0％，显示白芍总苷与柳氮磺砒啶疗效相近，白芍总苷能改善临床实验观察指标，耐受性与柳氮磺砒啶相似，其主要不良反应为腹泻。结论白芍总苷用于治疗AS具有良好的安全性和疗效。     

泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

Thirty patients with confirmed primary sjogren syndrome and thrombocytopenia during January 2002 and December 2007 were investigated.All the participants received 0.5 mg·kg-1·d-1 Prednisone and 100 ms/d CosA for 1 year.Clinical symptoms and the levels of white blood eell.platelet count,erythrocyte sedimentation rate,liver function,immunoglobin,and rheumatoid factors were recored before and after the treatment.After one-year follow.up,platelet count was elevated(t=11.4179,P< 0.01).There was no significant change in erythrocyte sedimentation rate.The concentrations of immunoglobin and rheumatoid factors were significantly decreased at 1 year(t=5.4222,P<0.01;t= 9.2857.P<0.01).Prednisone plus CosA could effectively treat primary sjOgren syndrome combined with thrombocytopenia and result in fewer side effects.     

泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

我院2002年1月至2007年12月确诊为干燥综合征的30例患者,均伴有血小板明显减少,维持在（20～50）×10^9/L至少3个月以上。给予泼尼松0．5mg·kg^-1·d^-1及环孢素A100mg／d治疗,疗程1年,观察患者临床症状,定期检测血常规、肝功能、红细胞沉降率、免疫球蛋白、类风湿因子等。结果显示,治疗1年后患者血小板明显升高,由（33±21）×10^9／L升至（115±30）×10^9/L（t=11．4179,P〈0．01）,免疫球蛋白、类风湿因子水平较治疗前明显下降（t值分别为5．4222,9．2857,均P〈0．01）性,红细胞沉降率无明显变化。提示泼尼松联合环孢素A治疗pSS合并顽固性血小板减少的疗效明显,不良反应小。     

泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

Thirty patients with confirmed primary sjogren syndrome and thrombocytopenia during January 2002 and December 2007 were investigated.All the participants received 0.5 mg·kg-1·d-1 Prednisone and 100 ms/d CosA for 1 year.Clinical symptoms and the levels of white blood eell.platelet count,erythrocyte sedimentation rate,liver function,immunoglobin,and rheumatoid factors were recored before and after the treatment.After one-year follow.up,platelet count was elevated(t=11.4179,P< 0.01).There was no significant change in erythrocyte sedimentation rate.The concentrations of immunoglobin and rheumatoid factors were significantly decreased at 1 year(t=5.4222,P<0.01;t= 9.2857.P<0.01).Prednisone plus CosA could effectively treat primary sjOgren syndrome combined with thrombocytopenia and result in fewer side effects.     

泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

Thirty patients with confirmed primary sjogren syndrome and thrombocytopenia during January 2002 and December 2007 were investigated.All the participants received 0.5 mg·kg-1·d-1 Prednisone and 100 ms/d CosA for 1 year.Clinical symptoms and the levels of white blood eell.platelet count,erythrocyte sedimentation rate,liver function,immunoglobin,and rheumatoid factors were recored before and after the treatment.After one-year follow.up,platelet count was elevated(t=11.4179,P< 0.01).There was no significant change in erythrocyte sedimentation rate.The concentrations of immunoglobin and rheumatoid factors were significantly decreased at 1 year(t=5.4222,P<0.01;t= 9.2857.P<0.01).Prednisone plus CosA could effectively treat primary sjOgren syndrome combined with thrombocytopenia and result in fewer side effects.     

专科护生疼痛管理知识和态度的调查分析

[目的]了解专科护生疼痛管理知识和态度的状况,为改进疼痛管理教育提供科学的参考依据。[方法]采用中文版疼痛管理知识和态度调查问卷(KASRP)对240名实习前的护生进行专科护生疼痛管理知识和态度的调查。[结果]KASRP问卷总分为16.89分±3.24分,得分范围为7分~24分,得分指标为42.22%;KASRP问卷答对率在17.5%~60.0%(42.22%±8.09%)。[结论]专科护生疼痛管理的知识和态度存在较明显的不足,建议院校开展针对性的疼痛管理相关的教育,以提高专科护生疼痛管理的能力。     

一体式教学与能力培养在形象设计中的应用与体会

目的通过对高职高专学生授课内容的精心设计,使医学美学与形象设计这门课内容具体化、真实化,操作性更强,更能激发学生的学习兴趣,同时达到设计更具有可比性。方法根据研究设计内容将"教、学、做、评、矫"一体教学运用于相对抽象的美学素质培养课程当中。医疗美容技术专业学生根据教师上课所列举的临床案例在课堂外测量,同时分析头面部的美学标志,真正做到理论联系实际。结果一体式教学与能力培养能够及时发现问题,解决问题,激发了学生的学习兴趣,提高了学习的主观能动性,培养学生的自学能力。结论学生能力的培养需要老师的充分备课及其课堂内容的精简与细化,学生将审美素能与美容外科、美容美体技术、造型设计等课程的审美要求结合起来,既将所学内容加以巩固,又加强了对于各科课程重要性的认识,并使自己懂得如何将各门学科知识相结合以求得更好的运用知识。     

泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

Thirty patients with confirmed primary sjogren syndrome and thrombocytopenia during January 2002 and December 2007 were investigated.All the participants received 0.5 mg·kg-1·d-1 Prednisone and 100 ms/d CosA for 1 year.Clinical symptoms and the levels of white blood eell.platelet count,erythrocyte sedimentation rate,liver function,immunoglobin,and rheumatoid factors were recored before and after the treatment.After one-year follow.up,platelet count was elevated(t=11.4179,P< 0.01).There was no significant change in erythrocyte sedimentation rate.The concentrations of immunoglobin and rheumatoid factors were significantly decreased at 1 year(t=5.4222,P<0.01;t= 9.2857.P<0.01).Prednisone plus CosA could effectively treat primary sjOgren syndrome combined with thrombocytopenia and result in fewer side effects.     

泼尼松联合环孢素A治疗干燥综合征合并血小板减少的临床观察

Thirty patients with confirmed primary sjogren syndrome and thrombocytopenia during January 2002 and December 2007 were investigated.All the participants received 0.5 mg·kg-1·d-1 Prednisone and 100 ms/d CosA for 1 year.Clinical symptoms and the levels of white blood eell.platelet count,erythrocyte sedimentation rate,liver function,immunoglobin,and rheumatoid factors were recored before and after the treatment.After one-year follow.up,platelet count was elevated(t=11.4179,P< 0.01).There was no significant change in erythrocyte sedimentation rate.The concentrations of immunoglobin and rheumatoid factors were significantly decreased at 1 year(t=5.4222,P<0.01;t= 9.2857.P<0.01).Prednisone plus CosA could effectively treat primary sjOgren syndrome combined with thrombocytopenia and result in fewer side effects.